Bank Julius Baer & Co. Ltd Zurich trimmed its stake in Humana Inc. (NYSE:HUM) by 66.4% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 958 shares of the insurance provider’s stock after selling 1,896 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in Humana were worth $397,000 as of its most recent filing with the SEC.
Several other institutional investors also recently added to or reduced their stakes in HUM. Morgan Stanley raised its stake in shares of Humana by 1.5% in the 1st quarter. Morgan Stanley now owns 332,161 shares of the insurance provider’s stock valued at $104,305,000 after acquiring an additional 4,850 shares during the period. SG Americas Securities LLC raised its stake in shares of Humana by 118.7% in the 2nd quarter. SG Americas Securities LLC now owns 2,239 shares of the insurance provider’s stock valued at $868,000 after acquiring an additional 14,224 shares during the period. Assenagon Asset Management S.A. purchased a new stake in shares of Humana in the 2nd quarter valued at approximately $861,000. Cerebellum GP LLC purchased a new stake in shares of Humana in the 2nd quarter valued at approximately $26,000. Finally, CWM LLC raised its stake in shares of Humana by 19.4% in the 2nd quarter. CWM LLC now owns 166 shares of the insurance provider’s stock valued at $64,000 after acquiring an additional 27 shares during the period. 92.43% of the stock is currently owned by institutional investors and hedge funds.
A number of equities research analysts have recently issued reports on HUM shares. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Humana from $397.00 to $431.00 and gave the company a “hold” rating in a research note on Thursday, September 10th. Credit Suisse Group lifted their price objective on shares of Humana from $423.00 to $465.00 and gave the company an “outperform” rating in a report on Wednesday, November 4th. Oppenheimer lifted their price objective on shares of Humana from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Wednesday, November 4th. SVB Leerink lifted their price objective on shares of Humana from $465.00 to $496.00 and gave the company an “outperform” rating in a report on Thursday, August 6th. Finally, Mizuho lifted their price objective on shares of Humana from $420.00 to $462.00 and gave the company a “buy” rating in a report on Friday, August 7th. Eight investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $447.35.
Shares of NYSE HUM opened at $406.21 on Friday. The stock has a market cap of $53.76 billion, a price-to-earnings ratio of 13.02, a PEG ratio of 1.96 and a beta of 0.94. Humana Inc. has a 52 week low of $208.25 and a 52 week high of $474.70. The company’s 50-day moving average price is $426.69 and its 200 day moving average price is $404.01. The company has a current ratio of 1.81, a quick ratio of 1.69 and a debt-to-equity ratio of 0.38.
Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, November 3rd. The insurance provider reported $3.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.81 by $0.27. Humana had a net margin of 5.58% and a return on equity of 22.74%. The company had revenue of $20.08 billion for the quarter, compared to analysts’ expectations of $18.59 billion. During the same period last year, the company earned $5.03 EPS. The firm’s revenue for the quarter was up 23.6% compared to the same quarter last year. As a group, research analysts expect that Humana Inc. will post 18.74 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 31st will be paid a dividend of $0.625 per share. The ex-dividend date is Wednesday, December 30th. This represents a $2.50 annualized dividend and a dividend yield of 0.62%. Humana’s dividend payout ratio is currently 13.99%.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Story: How is a management fee different from a performance fee?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.